ADVERSE REACTIONS
Adverse experiences with SUCRAID in clinical trials were
generally minor and were frequently associated with the underlying disease.
In clinical studies of up to 54 months duration, physicians treated a total
of 52 patients with SUCRAID. The adverse experiences and respective number of
patients reporting each event (in parenthesis) were as follows: abdominal pain
(4), vomiting (3), nausea (2), diarrhea (2), constipation (2), insomnia (1)
headache (1) nervousness (1) and dehydration (1).
Note: diarrhea and abdominal pain can be a part of the clinical presentation
of the genetically determined sucrase deficiency, which
is part of congenital sucrase-isomaltase deficiency (CSID).
One asthmatic child experienced a serious hypersensitivity reaction
(wheezing) probably related to sacrosidase (see Warnings). The event resulted in
withdrawal of the patient from the trial but resolved with no sequelae.
|